Insider Transactions in Q1 2021 at Prevail Therapeutics Inc. (PRVL)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 22
2021
|
Peter A. Thompson Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
13,822,463
-100.0%
|
-
|
|
Jan 22
2021
|
Carl L Gordon Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
13,822,463
-100.0%
|
-
|
|
Jan 22
2021
|
Ran Nussbaum Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
1,576,881
-100.0%
|
-
|
|
Jan 22
2021
|
Francois Nader Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
23,747
-100.0%
|
-
|
|
Jan 22
2021
|
Emily Minkow Chief Business Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,000
-100.0%
|
-
|
|
Jan 22
2021
|
Asa Abeliovich President & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,385,756
-100.0%
|
-
|
|
Jan 22
2021
|
Orbimed Advisors LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
13,822,463
-100.0%
|
-
|
|
Jan 22
2021
|
Tyto Acquisition Corp > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
34,284,789
+100.0%
|
$754,265,358
$22.5 P/Share
|